ORIGINAL RESEARCH
Accepted on 25 Sep 2025
Efficacy and safety of apalutamide, abiraterone acetate, and bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer
doi 10.3389/fonc.2025.1656216
- 315 views
- Frontiers in Endocrinology
- Cancer Endocrinology
- Research Topics
- Advancements in targeted therapies for genitourinary cancers
Advancements in targeted therapies for genitourinary cancers
700
Total downloads
5,050
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 08 Sep 2025
Case report series: Pembrolizumab and enfortumab vedotin in plasmacytoid urothelial carcinoma
doi 10.3389/fonc.2025.1608291
- 870 views
REVIEW
Published on 03 Sep 2025
Mechanism of action of HMGB1 in urologic malignancies
doi 10.3389/fonc.2025.1593157
- 1,450 views
CASE REPORT
Published on 01 Aug 2025
Pembrolizumab for treatment-related neuroendocrine prostate carcinoma with a high tumor mutational burden: a case report
doi 10.3389/fonc.2025.1642412
- 1,037 views
Published in
Frontiers in Endocrinology
Cancer Endocrinology
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: